The colt joined Bob Baffert’s stable at Santa Anita after arriving from Florida, where he was purchased at a sale for ...

Trainers Mick Price and Michael Kent Jr are expecting a “much improved” version of their promising colt Buggsy when he steps out in stakes company at Caulfield on Saturday. Trainers Mick Price and ...

Make this your preferred source to get more updates from this publisher on Google. Retailers on Monday announced another round of major pump price hikes, marking the 13th straight week of increases ...

I compared prices per ounce for 32 common grocery items on my list at Walmart and Costco. Costco had better prices but Walmart had more variety and no paid membership required to shop there. I'll buy ...

The Biden administration says Medicare recipients will save about $1.5 billion on out-of-pocket costs for medications to treat diabetes, heart disease, types of arthritis and other ailments under new ...

The Rajasthan Royals are stepping into a fresh and exciting phase for IPL 2026. With a change in leadership and some big, smart trades the “Men in Pink” have rebuilt their team with one clear goal to ...

The “Whistle Podu” fans are full of excitement as Chennai Super Kings (CSK) step into a new phase under captain Ruturaj Gaikwad. After a tough 2025 season. The five time champions have made big ...

Home prices are continuing to fall and inventory is rising, according to new Realtor.com data for the week ending March 14 — making way for a more buyer-friendly market. The report reveals that the ...

As fuel prices jump, farming is one industry that's feeling the pinch more than most. Pennsylvania farmers say economic factors like diesel fuel and fertilizer costs are pushing them to the edge. On ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. A number of major drugmakers have reportedly raised the prices of hundreds of brand-name drugs, including some of the ...

Amid efforts on several fronts to improve the affordability of its GLP-1 medications for diabetes and obesity, Novo Nordisk is taking a new approach by aiming straight for semaglutide’s list price.

Novo Nordisk on Tuesday said it plans to slash the monthly list prices of its popular obesity and diabetes drugs in the U.S. by up to 50% starting in 2027. The move aims to make the treatments more ...